![Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial - The Lancet Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial - The Lancet](https://www.thelancet.com/cms/attachment/2000988592/2003637687/gr1.gif)
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial - The Lancet
![Is aspirin an acceptable alternative to anticoagulant in a patient with deep vein thrombosis (DVT)? • The Blood Project Is aspirin an acceptable alternative to anticoagulant in a patient with deep vein thrombosis (DVT)? • The Blood Project](https://www.thebloodproject.com/wp-content/uploads/2022/06/image-21.png)
Is aspirin an acceptable alternative to anticoagulant in a patient with deep vein thrombosis (DVT)? • The Blood Project
![Effect of Low-Dose Aspirin on the International Normalized Ratio Variability in Patients with Mechanical Heart Valve Prostheses | Semantic Scholar Effect of Low-Dose Aspirin on the International Normalized Ratio Variability in Patients with Mechanical Heart Valve Prostheses | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a5119ed48ceca812a46daa6f851545456c5e5692/2-Table1-1.png)
Effect of Low-Dose Aspirin on the International Normalized Ratio Variability in Patients with Mechanical Heart Valve Prostheses | Semantic Scholar
![Aspirin for the Prevention of Recurrent Venous Thromboembolism The INSPIRE Collaboration – OncoPrescribe Aspirin for the Prevention of Recurrent Venous Thromboembolism The INSPIRE Collaboration – OncoPrescribe](http://www.oncoprescribe.com/app/uploads/_1421954819.jpg)
Aspirin for the Prevention of Recurrent Venous Thromboembolism The INSPIRE Collaboration – OncoPrescribe
![Antiplatelet and anticoagulant strategies in acute coronary syndrome: where we are in 2013 | Future Cardiology Antiplatelet and anticoagulant strategies in acute coronary syndrome: where we are in 2013 | Future Cardiology](https://www.futuremedicine.com/cms/10.2217/fca.13.21/asset/images/medium/figure1.gif)
Antiplatelet and anticoagulant strategies in acute coronary syndrome: where we are in 2013 | Future Cardiology
![Common anticoagulant drugs and target sites related to their primary... | Download Scientific Diagram Common anticoagulant drugs and target sites related to their primary... | Download Scientific Diagram](https://www.researchgate.net/publication/233389694/figure/fig2/AS:299944268320771@1448523694691/Common-anticoagulant-drugs-and-target-sites-related-to-their-primary-mechanism-of-action.png)
Common anticoagulant drugs and target sites related to their primary... | Download Scientific Diagram
![Antiplatelet and Anticoagulant Agents in Heart Failure: Current Status and Future Perspectives - ScienceDirect Antiplatelet and Anticoagulant Agents in Heart Failure: Current Status and Future Perspectives - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2213177913004101-gr1.jpg)
Antiplatelet and Anticoagulant Agents in Heart Failure: Current Status and Future Perspectives - ScienceDirect
![Dual Anticoagulant and Antiplatelet Therapy for Coronary Artery Disease and Peripheral Artery Disease Patients | Arteriosclerosis, Thrombosis, and Vascular Biology Dual Anticoagulant and Antiplatelet Therapy for Coronary Artery Disease and Peripheral Artery Disease Patients | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/51ebae56-7673-450f-a625-a5945ab02032/10ga01.jpg)
Dual Anticoagulant and Antiplatelet Therapy for Coronary Artery Disease and Peripheral Artery Disease Patients | Arteriosclerosis, Thrombosis, and Vascular Biology
![Antiplatelet therapy in acute coronary syndrome - Brown - 2017 - Continuing Cardiology Education - Wiley Online Library Antiplatelet therapy in acute coronary syndrome - Brown - 2017 - Continuing Cardiology Education - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/15d211d3-6d60-45e0-83bc-3321d9807a58/cce248-fig-0001-m.jpg)
Antiplatelet therapy in acute coronary syndrome - Brown - 2017 - Continuing Cardiology Education - Wiley Online Library
![Antithrombotics: From Aspirin to DOACs in Coronary Artery Disease and Atrial Fibrillation (Part 3/5) - ScienceDirect Antithrombotics: From Aspirin to DOACs in Coronary Artery Disease and Atrial Fibrillation (Part 3/5) - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109719354002-fx1.jpg)
Antithrombotics: From Aspirin to DOACs in Coronary Artery Disease and Atrial Fibrillation (Part 3/5) - ScienceDirect
![Is It Really Safe to Discontinue Antiplatelet Therapy 12 Months After Percutaneous Coronary Intervention in Patients with Atrial Fibrillation? | ICR Journal Is It Really Safe to Discontinue Antiplatelet Therapy 12 Months After Percutaneous Coronary Intervention in Patients with Atrial Fibrillation? | ICR Journal](https://assets.radcliffecardiology.com/s3fs-public/article/2023-06/500.jpg?VersionId=QZ376vFaAmUdbLGUwG_5GebzZ4TY0M33)
Is It Really Safe to Discontinue Antiplatelet Therapy 12 Months After Percutaneous Coronary Intervention in Patients with Atrial Fibrillation? | ICR Journal
![Aspirin Instead of Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Risk for Stroke - ScienceDirect Aspirin Instead of Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Risk for Stroke - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109716327693-gr2.jpg)